Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[eIF3a gene polymorphism and chemo-sensitivity to platinum-based drugs in ovarian cancer].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences - 1 Jun 2015

Zhang Caiyi, Zhang Shufen, Liu Yingzi, Tian Yan, Li Xinguo, Zhang Yu

Abstract excerpt

OBJECTIVE: To investigate the relationship between the eukaryotic initiation factor 3a (eIF3a)polymorphisms and chemo-sensitivity to platinum-based drug in ovarian cancer. METHODS: Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis was performed to detect 57 cases of eIF3a polymorphic genotypes (rs3824830, rs77382849, rs10787899 and rs3740556) after platinum-based...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Eukaryotic Initiation Factor-3
Share to Genotype
Share to Mutation
Share to Ovarian Neoplasms
Share to Platinum
Share to Polymorphism, Genetic
Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source

Identifiers

PMID: 26164510
DOI: 10.11817/j.issn.1672-7347.2015.06.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[eIF3a gene polymorphism and chemo-sensitivity to platinum-based drugs in ovarian cancer].PMID 26164510Read ↗

The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients.Semantic proximity Read ↗

Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.Semantic proximity Read ↗

Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.Semantic proximity Read ↗

The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma.Semantic proximity Read ↗

Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.Semantic proximity Read ↗

Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer.Semantic proximity Read ↗

INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.Semantic proximity Read ↗

Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC.Semantic proximity Read ↗

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Semantic proximity Read ↗

Rs3802278 in 3'-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients.Semantic proximity Read ↗

[Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].Semantic proximity Read ↗

[Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.